Single Source Procurement: Cystic Fibrosis Test Kits and Reagents

Pursuant to New York State Finance Law § 163.10(b), The New York State Department of Health is presenting the following summary of relevant circumstances, and material and substantial reasons why a competitive procurement was not feasible. The Illumina MiSeqDx platform and application are the only FDA approved next generation sequencing system for in-vitro use within a clinical laboratory.

Procurement / Program Name Cystic Fibrosis Test Kits and Reagents
Contractor Name(s) Illumina, Inc.
Contract Period 5/23/18 - 3/31/19
Contract Number OP033850